Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
This paper presents mechanism of action and antimicrobial spectrum of macrolides as well as the known acquired resistance mechanisms in the common pathogens causing community-acquired pneumonia, such as Streptococcus pneumoniae and Mycoplasma pneumoniae. Non-antimicrobial (anti-inflammatory and immu...
Main Authors: | Sinopalnikov A.I., Rachina S.A., Zakharenkov I.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2019-12-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2019/3/cmac-2019-t21-n3-p217/cmac-2019-t21-n3-p217.pdf |
Similar Items
-
Macrolides and their role in the treatment of community-acquired pneumonia of various etiology
by: I. V. Leschenko, et al.
Published: (2015-12-01) -
Macrolides in the modern therapy of community-acquired pneumonia in children
by: Yu. L. Mizernitskiy
Published: (2020-11-01) -
Macrolide-resistant <it>Mycoplasma pneumoniae</it> in adolescents with community-acquired pneumonia
by: Miyashita Naoyuki, et al.
Published: (2012-05-01) -
Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
by: AliReza Eshaghi, et al.
Published: (2013-09-01) -
Community-acquired pneumonia in adults: Approaches to antibacterial therapy in the context of current clinical guidelines
by: A I Sinopalnikov
Published: (2010-08-01)